Relevant publications

Waltereit-Kracke V, Wehmeyer C, Beckmann D, Werbenko E, Reinhardt J, Geers F, Dienstbier M, Fennen M, Intemann J, Paruzel P, Korb-Pap A, Pap A, Dankbar B
Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis.
Annals of Rheumatic Diseases (2022)

Beckmann D, Römer-Hillmann A, Krause A, Hansen U, Wehmeyer C, Intemann J, de Gorter DJJ, Dankbar B, Hillen J, Heitzmann M, Begemann I, Galic M, Weinhage T, Foell D, Rizi A,  Kremerskothen J, Kiener HP, Müller S, T Kamradt T, Schröder C, Leitão E, Horsthemke B, Rosenstiel P, Nordström K, Gasparoni G, Gasparoni N, Walter J, Li N, Yang X, Chung HR, Pavenstädt H, Lindemann N, Schnittler HJ, Wang W, Firestein GS, Pap T, Korb-Pap A
LASP1 regulates adherens junction dynamics and fibroblast transformation in destructive arthritis.
Nature Communications (2021)

Croft AP, Campos J, Jansen K, Turner J, Marshall J, Attar M, Savary L, Perlman H, Barone F, McGettrick H, Fearon D, Wei K, Raychaudhuri S, Korsunsky I, Brenner M, Coles M, Sansom S, Filer A, Wehmeyer C, Naylor A, Kemble S, Begum J, Dürholz K, Buckley C
Distinct fibroblast subsets drive inflammation and tissue damage in arthritis.
Nature (2019)

Wehmeyer C, Frank S, Beckmann D, Korb-Pap A, Cromme C, Böttcher M, Kamradt T, Kramer I, Kneissel M, Stratis A, König U, Fennen M, Held A, Paruzel P, Hartmann C, van den Berg W, Pap T, Dankbar B
Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction.
Science Translational Medicine (2016)

Dankbar B, Fennen M, Brunert D, Hayer S, Frank S, Wehmeyer C, Beckmann D, Paruzel P, Bertrand J, Redlich R, Koers-Wunrau C, Stratis A, Korb-Pap A, Pap T
Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.
Nature Medicine (2015)

To get an overview of all our publications please see our IMM publication list: https://www.medizin.uni-muenster.de/imm/forschung/publikationen.html